<DOC>
	<DOCNO>NCT01789294</DOCNO>
	<brief_summary>Aim prospective , parallel multi-arm , randomize , clinical trial , compare clinical outcome patient Methods.We recruit child undergone diagnostic colonoscopy Umberto I Pediatric Department ( Rome , Italy ) 2008 2010 . Eligibility criterion : 1 ) demonstration LNH ; 2 ) concomitant disease ; 3 ) treatment assume since clinical onset . Patients allocate 1:1:1 dietetic ( Group A ) v mesalamine ( Group B ) v treatment ( Group C ) 8-weeks period . Skin prick test patch test common food , symptom score baseline follow perform blinded clinician . Chi-square test trend use compare frequency symptom score improvement ( &gt; 1 point ) among group . The association baseline feature patient clinical response estimate frequency analysis .</brief_summary>
	<brief_title>Clinical Management Childhood Intestinal Lymphoid Nodular Hyperplasia</brief_title>
	<detailed_description>Lymphoid nodular hyperplasia ( LNH ) low gastrointestinal tract common find pediatric colonoscopy , whose clinical significance yet clearly establish . Although initially consider normal , age-related variant , author recently suggest regard LNH marker food allergy ( FA ) .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>1. isolated find LNH [ 18 ] , define demonstration significant cluster lymphoid nodule ( &gt; 10/visible field ) endoscopy lymphoid follicle hyperplasia hystology ; 2. negative result preliminary evaluation 1. diagnosis concomitant inflammatory , rheumatic infectious disease , 2. assumption dietetic therapy since clinical onset .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>lymphoid nodular hyperplasia</keyword>
	<keyword>food allergy</keyword>
</DOC>